Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 2455 Open Access articles, 5471 Scientific conference Proceedings , 705 National symposiums and 2567 speakers, 2160 Editors, 57 Journals, 10 e-Book, 2 Societies, 3 Collaborations on Key word Cancer in Global Events page. Global Events of Conference series are presently dedicated exclusively to biobank and about 2,070 articles are being published on Tissue Science & Engineering.
The Cancer Human Biobank (caHUB) is a BBRB derived program that carries out specialized biospecimen and data procurements to support biospecimen science activities. The caHUB network consists of the following components: Biospecimen Source Sites (BSSs) are organizations, such as academic medical centers, rapid autopsy centers, and organ procurement organizations, that obtain patient consent, acquire specimens, and ship them to one of a number of program sites. The Comprehensive Biospecimen Resource (CBR) is a centralized site that assembles collection and shipping kits, receives most biospecimens from the BSSs for processing and storage, and ships biospecimens from the BSSs to the processing and analysis facilities. The CBR also generates H&E sections from FFPE blocks and produces digital images of these sections. The Comprehensive Data Resource (CDR) is a centralized data storage facility that obtains patient and specimen data from BSSs and other program sites that handle and analyze samples. The Pathology Resource Center (PRC) is a network of board certified pathologists who review H&E sections from caHUB collected specimens as a quality control measure and also provide technical direction for caHUB biospecimen collections. Molecular Analysis Facilities (MAFs) carry out molecular analysis on caHUB collected specimens. MAFs can be individuals or organizations from government, academia, or private industry entities. Every year over 140,000 new cancer cases are diagnosed in the state of Texas resulting in approximately 40,000 deaths. The probability of effective treatment with a targeted therapeutic can be improved for patients with defined genotypes Specimens were collected according to the TCRB Standard Operating Procedures to ensure the highest quality tissues. Specimens were first characterized by a TCRB pathologist. Tissues were also processed for DNA/RNA isolation & sequencing, tissue storage and xenograft/cell line derivation. Data from the specimens, their DNA/RNA sequence, and limited clinical information were linked together in TCRB's Acquire database.
OMICS International Organizes 1000+ Global Events. Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Accesswhich contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The Conference series website will provide you list and details about the conference organize worldwide.
Scope & Importance
A 2011 survey of more than 700 cancer researchers found that 47% had trouble finding samples of sufficient quality. Because of this, 81% have reported limiting the scope of their work, and 60% said they question the findings of their studies. Worse than having nothing to analyze are analytes that change in unpredictable ways. One study showed that the concentration of two cancer biomarkers seemed to increase by around 15% from the time that the serum samples were collected and frozen to when they were thawed and measured again about 10 years later. In another experiment5, designed to simulate long-term freezing, researchers examined how several cancer biomarkers changed in serum samples that were frozen and then thawed. Some protein biomarkers seemed to be stable for decades even with multiple freeze–thaw cycles. However, vascular endothelial growth factor — an extensively studied biomarker implicated in diabetes, arthritis and cancer — was so unstable that the authors recommended that it should never be measured in samples that have been frozen. Systems from companies such as Hamilton Storage Technologies in Hopkinton, Massachusetts, start at around US$1 million and can hold between 250,000 and 10 million samples. A typical epidemiological study might have 100,000 samples from 10,000 patients that would fill five freezers, each of which costs $6,000 a year to maintain properly, says Jim Vaught, deputy director of the National Cancer Institute's Office of Biorepositories and Biospecimen Research (OBBR). Scientists studying the effects of a particular gene on a cancer pathway could save years of effort and thousands of dollars if they have ready access to a collection of tumour samples with mutations of interest. David Cox, a senior vice-president at drug-company Pfizer and a member of the BBMRI's scientific advisory board, believes that the way to get the most out of biological specimens is not prospectively banking samples but finding ways to reuse samples that researchers have already collected for their own questions.
List of Conferences:
Molecular Biology Conference
October 13-15, 2016 Dubai, UAE
Synthetic Biology Conference
September 28-30, 2015 Houston, USA
Stem Cell Society Singapore 2015 Symposium: Opportunities & Challenges in Stem Cell Based Medicine
17-18 November 2015 Biopolis, Singapore
3rd International Congress on Controversies to Stem Cell Transplantation and Cellular Therapies (COSTEM)
22-25 October 2015 Berlin, Germany
Relevant societies and associations:
This page will be updated regularly.
This page was last updated on May 10, 2021